NOF CORPORATION is pleased to announce that it will attend BIO Partnering at JPM Week 2026, which will be held at San Francisco MarriottMarquis, 780 Mission Street, San Francisco, CA, U.S.A. from January 12 to 15.
NOF CORPORATION is pleased to announce its participation in the upcoming SITC 2025
NOF Corporation joins the LNP Alliance, bringing advanced lipid expertise to accelerate lipid nanoparticle drug development.
NOF CORPORATION is pleased to announce its participation in the upcoming Partnerships Opportunities in Drug Delivery (PODD) 2025, which will be held at Westin Copley Place, Boston, MA, USA on October 27 and 28.The company is a Technology...
Polysorbate 80 (HX2)™, NOF AMERICA’s ultrapure polysorbate 80, has achieved compliance with USP, EP, JP, and the Chinese Pharmacopoeia (ChP for injection), enabling pharmaceutical product development for the Chinese market.
